Novo Nordisk A/S Sponsored ADR (NVON)
BMV
Real-time Data
02:30 PM
Day's Range
789.0052 wk Range
637.43Overview - NVON - Novo Nordisk A/S Sponsored ADR
Key Statistics
Valuation
Enterprise Value
9.50T
P/E (Trailing)
‪11.37‬
PEG Ratio
‪-0.55‬
Price / Sales (TTM)
‪10.62‬
Price / Book
‪5.99‬
EV / EBITDA
‪20.72‬
Profitability
Gross Margin
‪78.21%‬
Profit Margin
‪35.34%‬
Operating Margin
‪42.54%‬
Return on Assets
‪18.72%‬
Return on Equity
‪59.81%‬
Ownership
Shares Outstanding
4.42B
Float
3.17B
Held by Insiders
‪0.0030%‬
Held by Institutions
‪9.90%‬
Price stats
Beta
‪0.34‬
50-Day Avg
‪826.82‬
200-Day Avg
‪816.83‬
Dividends
Payout Ratio
‪44.46%‬
Frequency
Semi-Annual
Market Cap - NVON - Novo Nordisk A/S Sponsored ADR
Peers - NVON - Novo Nordisk A/S Sponsored ADR
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on BMV.
Profile Summary - NVON - Novo Nordisk A/S Sponsored ADR
About
Novo Nordisk A/S Sponsored ADR is a global healthcare company focused on discovering, developing, manufacturing, and marketing pharmaceutical products. Novo Nordisk A/S Sponsored ADR serves patients and healthcare providers through two main business segments: Diabetes and Obesity Care, which includes therapies for…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
